Longevity Biotech Stocks Rise Amid $27T Healthcare Shift
Issued on behalf of Avant Technologies Inc. USA News Group News Commentary – Global capital is officially rotating into “Longevity Infrastructure” which is now valued at a...
Tag : biotechnology company
WallachBeth Closes $1.8M Direct Stock Financing for bioAffinity
WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW), a biotechnology company focused...
bioAffinity Prices $4.8M Public Offering via WallachBeth
WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (NASDAQ: BIAF and BIAFW) a biotechnology company focused on the need...
XellSmart Gets FDA Clearance for 3 Phase I INDs in CNS Cell Therapies
XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived cell therapies. To date, the company has...
bioAffinity Technologies Announces Pricing of $3.25 Million Offering
bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced that it has...
Ray Therapeutics Gets $8M CIRM Grant for RP Gene Therapy
Funding will support ongoing clinical development of optogenetic therapy to restore vision Ray Therapeutics, a biotechnology company developing optogenetic gene therapies for vision restoration, today...
Nuclera Enhances eProtein Discovery for Membrane Protein Production
Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced the addition of a new membrane protein workflow...
Sensorion Ends Patient Inclusion in NOTOXIS Phase 2a Trial
Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today...
OS Therapies Gets Patent Allowance for OST-HER2 Manufacturing
Patent Term Adjustment will provide market exclusivity in the United States into 2040 for all therapeutic indications OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology...
Pheast Appoints Dr. Raphaël Rousseau as Chief Medical Officer
Dr. Rousseau to lead clinical development as Pheast advances PHST001, a novel anti-CD24 macrophage checkpoint inhibitor, into clinical trials Pheast Therapeutics, a private biotechnology company...
Navega Therapeutics Gets CIRM Grant for Chronic Pain Treatment
Next-generation AAV gene therapy targets intractable chronic pain Navega Therapeutics, a biotechnology company developing epigenetic gene therapies, today announced the receipt of a $4M Translational Science grant...
Osta Therapeutics adds two experts to tackle antibiotic resistance
Osta Therapeutics, a biotechnology company developing smart drugs to fight antibiotic resistance, today announced the appointments of Dr. Gilles Courtemanche as Senior Scientific Advisor and...